An innovative, Houston-created tool instantly chills wine and spirits. Photo via thecoldcork.com

Great inventions reveal their value within due course, but there are those creations that tell their worth almost immediately, with a first look, image, or mere mention.

The Cold Cork, a malleable pouring device that instantly chills wine and spirits, falls into that category.

It seems like such a simple idea, but that’s the thing about inventions, isn’t it? Anyone can come up with an idea, but it’s the ones that can execute that idea that make it to the finish line and etch their names in the annals of creative glory.

“I had come home from the grocery store, right at the onset of COVID, and I wanted to have a glass of wine that I bought, but it was already room temperature, and I didn't want to put ice in it,” says wine-lover and former healthcare worker Michelle Kurkiewicz. “So, we started doing some research and came up with the idea for Cold Cork.”

Timing is everything, and because the nationwide pause caused by the COVID-19 pandemic offered Michelle, 33, and her husband Tyler, 30, plenty of free time, the dutiful duo was able to flesh out their labor of love.

Tyler and Michelle Kurkiewicz came up with the idea of the Cold Cork. Photo via thecoldcork.com

As it turns out, Tyler, a mechanical engineer by trade, had recently purchased a 3D printer back in January 2020, so he was able to use it to build hundreds of prototypes in-house to eventually arrive at a final design, which is based on the couple’s wedding champagne flutes.

So how does the Cold Cork work? Picture this: the wine-lover takes the Cold Cork out of the freezer (after a recommended 24 hours to thoroughly freeze), places it on top of the open bottle of wine and begins to pour.

As the liquid funnels through the stainless-steel coil, which is surrounded by a proprietary, food-grade cooling medium, the wine or spirits is chilled by 20 degrees in just 20 seconds.

To achieve the best results for red wine, pour the entire bottle through the Cold Cork into a decanter and enjoy.

And the best part? Not one part of the Cold Cork’s signature process alters the taste or composition of the drink in any way.

The device, priced at $64.95, chills liquids 20 degrees in 20 seconds. Photo via thecoldcork.com

“At first, we thought about whether the product should be inside the bottle or outside the bottle,” remembers Tyler. “But we quickly realized that there’s simply not enough room to do that amount of chilling inside a bottle. And we didn't want to have to pour any wine out. But we needed to make space to put some sort of chiller in the bottle. And so, we immediately started looking outside the bottle, and just with all the other wine gadgets, being bottle-topped and plugging in with a rubber stopper, that's immediately the direction we sort of drifted to.”

According to Tyler, the first couple of prototypes were made of a 3D filament. Initially, the idea was to focus on creating a cooling gel to compliment the coil, but that got a bit messy and, of course, there were too many wine taste-testing sessions to count.

“We definitely went through a lot of bottles of wine,” says Michelle. “But one of the first people that used our product was a sommelier and she loved it. We also gave one of our first production-level prototypes to a friend who is a manager at a restaurant. She used it on several occasions and said it was perfect for what she needed and seeing our product be used at a place that we frequented was extremely validating.”

Armed with the validation they needed to go to production, the wine-loving public could now have the product they needed to keep from having to throw all their wine in the refrigerator.

“The Cold Cork is really good for the people that maybe don't have those multi-zone fridges,” says Michelle. “We found a good niche with entry-level wine drinkers that don't have a wine fridge, but they want to drink their white wines still without being over-drank with ice cubes.

“That's really who we've been going after, and who we've seen has found a lot of value in the product. It's really the people that maybe aren't so prepared or maybe looking just for some more accessible solutions, whether it's because of the space in their apartment or financially, you know, it might be cheaper than a wine fridge. That's why we came up with the Cold Cork ourselves, because that was us, and so we kind of made a product that worked for us and found that there are a lot of people like that.”

The Cold Cork is available now and can be purchased directly from the company’s website for $64.95. In the future, more cork sizes and different colors will be offered, and more brick-and-mortar stores will carry the product. The couple pitched the idea and received investment from Trend Ventures at the 2022 Build Up Buttercup, an initiative that featured small business pitches for a select group of investors.

“We’ve gotten a lot of feedback directly from customers saying they use it a lot more than they thought,” says Michelle. “But then there are those people that are skeptical about how it works. That’s why I love to demo the Cold Cork in person.”

For a couple that met at a bar one night in downtown Houston, the Cold Cork is almost a poetic destination as a business endeavor and one that they both really relish.

“We both have our strengths, and we give each other a lot of support,” says Michelle.

“I’m very mechanically inclined, so I develop and invent, and Michelle is great with the marketing aspect and working with people to purchase the product,” adds Tyler. “In addition to the Cold Cork, we do have a couple of early projects that we are working on. I think there is a lot of opportunity with our technology to take what we have learned and fit that into different product lineups moving forward.”

Cold Cork Thermometer Test

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Texas tops ranking of best state for investors in new report

by the numbers

Texas ranks third on a new list of the best states for investors and startups.

Investment platform BrokerChooser weighed five factors to come up with its ranking:

  • 2024 Google search volume for terms related to investing
  • Number of investors
  • Number of businesses receiving investments in 2024
  • Total amount of capital invested in businesses in 2024
  • Percentage change in amount of investment from 2019 to 2024

Based on those figures, provided mostly by Crunchbase, Texas sits at No. 3 on the list, behind No. 1 California and No. 2 New York.

Especially noteworthy for Texas is its investment total for 2024: more than $164.5 billion. From 2019 to 2024, the state saw a 440 percent jump in business investments, according to BrokerChooser. The same percentages are 204 percent for California and 396 percent for New York.

“There is definitely development and diversification in the American investment landscape, with impressive growth in areas that used to fly under the radar,” says Adam Nasli, head analyst at BrokerChooser.

According to Crunchbase, funding for Texas startups is off to a strong start in 2025. In the first three months of this year, venture capital investors poured nearly $2.9 billion into Lone Star State companies, Crunchbase data shows. Crunchbase attributes that healthy dollar amount to “enthusiasm around cybersecurity, defense tech, robotics, and de-extincting mammoths.”

During the first quarter of this year, roughly two-thirds of VC funding in Texas went to just five companies, says Crunchbase. Those companies are Austin-based Apptronik, Austin-based Colossal Biosciences, Dallas-based Island, Austin-based NinjaOne, and Austin-based Saronic.

Autonomous truck company rolls out driverless Houston-Dallas route

up and running

Houston is helping drive the evolution of self-driving freight trucks.

In October, Aurora opened a more than 90,000-square-foot terminal at a Fallbrook Drive logistics hub in northwest Houston to support the launch of its first “lane” for driverless trucks—a Houston-to-Dallas route on the Interstate 45 corridor. Aurora opened its Dallas-area terminal in April and the company began regular driverless customer deliveries between the two Texas cities on April 27.

Close to half of all truck freight in Texas moves along I-45 between Houston and Dallas.

“Now, we are the first company to successfully and safely operate a commercial driverless trucking service on public roads. Riding in the back seat for our inaugural trip was an honor of a lifetime – the Aurora Driver performed perfectly and it’s a moment I’ll never forget,” Chris Urmson, CEO and co-founder of Pittsburgh-based Aurora, said in a news release.

Aurora produces software that controls autonomous vehicles and is known for its flagship product, the Aurora Driver. The software is installed in Volvo and Paccar trucks, the latter of which includes brands like Kenworth and Peterbilt.

Aurora previously hauled more than 75 loads per week under the supervision of vehicle operators from Houston to Dallas and Fort Worth to El Paso for customers in its pilot project, including FedEx, Uber Freight and Werner. To date, it has completed over 1,200 miles without a driver.

The company launched its new Houston to Dallas route with customers Uber Freight and Hirschbach Motor Lines, which ran supervised commercial pilots with Aurora.

“Transforming an old school industry like trucking is never easy, but we can’t ignore the safety and efficiency benefits this technology can deliver. Autonomous trucks aren’t just going to help grow our business – they’re also going to give our drivers better lives by handling the lengthier and less desirable routes,” Richard Stocking, CEO of Hirschbach Motor Lines, added in the statement.

The company plans to expand its service to El Paso and Phoenix by the end of 2025.

“These new, autonomous semis on the I-45 corridor will efficiently move products, create jobs, and help make our roadways safer,” Gov. Greg Abbott added in the release. “Texas offers businesses the freedom to succeed, and the Aurora Driver will further spur economic growth and job creation in Texas. Together through innovation, we will build a stronger, more prosperous Texas for generations.”

In July, Aurora said it raised $820 million in capital to fuel its growth—growth that’s being accompanied by scrutiny.

In light of recent controversies surrounding self-driving vehicles, the International Brotherhood of Teamsters, whose union members include over-the-road truckers, recently sent a letter to Lt. Gov. Dan Patrick calling for a ban on autonomous vehicles in Texas.

“The Teamsters believe that a human operator is needed in every vehicle—and that goes beyond partisan politics,” the letter states. “State legislators have a solemn duty in this matter to keep dangerous autonomous vehicles off our streets and keep Texans safe. Autonomous vehicles are not ready for prime time, and we urge you to act before someone in our community gets killed.”

Houston cell therapy company launches second-phase clinical trial

fighting cancer

A Houston cell therapy company has dosed its first patient in a Phase 2 clinical trial. March Biosciences is testing the efficacy of MB-105, a CD5-targeted CAR-T cell therapy for patients with relapsed or refractory CD5-positive T-cell lymphoma.

Last year, InnovationMap reported that March Biosciences had closed its series A with a $28.4 million raise. Now, the company, co-founded by Sarah Hein, Max Mamonkin and Malcolm Brenner, is ready to enroll a total of 46 patients in its study of people with difficult-to-treat cancer.

The trial will be conducted at cancer centers around the United States, but the first dose took place locally, at The University of Texas MD Anderson Cancer Center. Dr. Swaminathan P. Iyer, a professor in the department of lymphoma/myeloma at MD Anderson, is leading the trial.

“This represents a significant milestone in advancing MB-105 as a potential treatment option for patients with T-cell lymphoma who currently face extremely limited therapeutic choices,” Hein, who serves as CEO, says. “CAR-T therapies have revolutionized the treatment of B-cell lymphomas and leukemias but have not successfully addressed the rarer T-cell lymphomas and leukemias. We are optimistic that this larger trial will further validate MB-105's potential to address the critical unmet needs of these patients and look forward to reporting our first clinical readouts.”

The Phase 1 trial showed promise for MB-105 in terms of both safety and efficacy. That means that potentially concerning side effects, including neurological events and cytokine release above grade 3, were not observed. Those results were published last year, noting lasting remissions.

In January 2025, MB-105 won an orphan drug designation from the FDA. That results in seven years of market exclusivity if the drug is approved, as well as development incentives along the way.

The trial is enrolling its single-arm, two-stage study on ClinicalTrials.gov. For patients with stubborn blood cancers, the drug is providing new hope.